Page 109 - 202008
P. 109
nal insufficiency following trastuzumab treatment for breast cancer patients:two case reports and a literature re-
breast cancer in pregnancy:case report und review of the view[J]. S Afr Med J,1997,87(11):1538-1539.
current literature[J]. Breast Care:Basel,2011,6(6): [32] ILLIDGE TM,HUSSEY M,GODDEN CW. Malignant
475-478. hypercalcaemia in pregnancy and antenatal administration
[17] TOBE M,STEPHEN C,VASANTHA K,et al. Breast can- of intravenous pamidronate[J]. Clin Oncol:R Coll Radiol,
cer in pregnancy:case report[J]. Pan Afr Med J,2010. 1996,8(4):257-258.
DOI:10.4314/pamj.v521.56195. [33] BARNI S,ARDIZZOIA A,ZANETTA G,et al. Weekly
[18] SZEKELY B,LANGMAR Z,SOMLAI K,et al. Treat- doxorubicin chemotherapy for breast cancer in pregnancy:
ment of pregnancy associated breast cancer[J]. Orv Hetil, a case report[J]. Tumori,1992,78(5):349-350.
2010,151(32):1299-1303. [34] LELLÉ RJ,BEISLER G,UNLU C. Effect of pregnancy
[19] LOGUE K. Pregnancy-associated breast cancer[J]. Clin J on metastasizing breast cancer:a case report[J]. Z Geburt-
Oncol Nurs,2009,13(1):25-27. shilfe Perinatol,1986,190(5):229-231.
[20] DIAMOND JR,FINLAYSON CA,THIENELT C,et al. [35] YILDIRIM N,BAHCECI A. Use of pertuzumab and
Early-stage BRCA2-linked breast cancer diagnosed in the trastuzumab during pregnancy[J]. Anticancer Drugs,
first trimester of pregnancy associated with a hypercoagu- 2018,29(8):810-813.
lable state[J]. Oncology:Williston Park,2009,23(9): [36] NARGOTRA N,KALITA D. Pregnancy associated breast
784-791. cancer:awareness is the key to diagnosis:a case report[J].
[21] WITZEL ID,MULLER V,HARPS E,et al. Trastuzumab J Clin Diagn Res,2015,9(11):9-11.
in pregnancy associated with poor fetal outcome[J]. Ann [37] YAO C,XIA H,WANG Y,et al. Long-term treatment af-
Oncol,2008,19(1):191-192. ter preoperative high-dose chemotherapy in a lactating
[22] SKRABLIN S,BANOVIC V,MATKOVIC V. Adriamy- breast cancer patient[J]. Cell Biochem Biophys,2014,69
cin and cyclophosphamide chemotherapy in advanced (1):61-64.
breast cancer in pregnancy[J]. Eur J Obstet Gynecol Re- [38] ALIPOUR S,SEIFOLLAHI A,ANBIAEE R. Lactating
prod Biol,2007,133(2):251-252. breast abscess:a rare presentation of adenosquamous
[23] SEKAR R,STONE PR. Trastuzumab use for metastatic breast carcinoma[J]. Singapore Med J,2013,54(12):
breast cancer in pregnancy[J]. Obstet Gynecol,2007,110 247-249.
(2 Pt 2):507-510. [39] ROKUTANDA N,IINO Y,YOKOE T,et al. Primary
[24] MARTINEZ-RAMOS D,FERRARIS C,GRECO M,et squamous cell carcinoma of the breast during lactation:a
al. Breast carcinoma during pregnancy[J]. Cir Esp,2007, case report[J]. Jpn J Clin Oncol,2000,30(6):279-282.
82(5):305-307. [40] LI T,MELLO-THOMS C,BRENNAN PC. Descriptive
[25] BODNER-ADLER B,BODNER K,ZEISLER H. Breast epidemiology of breast cancer in China:incidence,mortal-
cancer diagnosed during pregnancy[J]. Anticancer Res, ity,survival and prevalence[J]. Breast Cancer Res Treat,
2007,27(3b):1705-1707. 2016,159(3):395-406.
[26] KERR JR. Neonatal effects of breast cancer chemotherapy [41] LANGER A,MOHALLEM M,STEVENS D,et al. A sin-
administered during pregnancy[J]. Pharmacotherapy,2005, gle-institution study of 117 pregnancy-associated breast
25(3):438-441. cancers(PABC):presentation,imaging,clinicopathologi-
[27] KATZ MS,SCHAPIRA L,HARISINGHANI MG,et al. cal data and outcome[J]. Diagn Interv Imaging,2014,95
Palpable right breast mass in a pregnant woman[J]. Nat (4):435-441.
Clin Pract Oncol,2005,2(4):218-221. [42] OPDAHL S,ALSAKER MD,JANSZKY I,et al. Joint ef-
[28] ISHIKAWA T,HAMAGUCHI Y,MOMIYAMA N,et al. fects of nulliparity and other breast cancer risk factors[J].
Pregnancy-associated breast cancer with multiple metasta- Br J Cancer,2011,105(5):731-736.
ses[J]. Eur J Surg,2002,168(7):428-430. [43] DURRANI S,AKBAR S,HEENA H. Breast cancer dur-
[29] DE SANTIS M,LUCCHESE A,DE CAROLIS S,et al. ing pregnancy[J]. Cureus,2018. DOI:10.7759/cureus.2941:
Metastatic breast cancer in pregnancy:first case of chemo- e2941.
therapy with docetaxel[J]. Eur J Cancer Care:Engl,2000, [44] TRAVIS RC,KEY TJ. Oestrogen exposure and breast can-
9(4):235-237. cer risk[J]. Breast Cancer Res,2003. DOI:10.1186/bcr628.
[30] ZANCONATI F,ZANELLA M,FALCONIERI G,et al. [45] JOHANSSON ALV,ANDERSSON TM,HSIEH CC,et
Gestational squamous cell carcinoma of the breast:an un- al. Tumor characteristics and prognosis in women with
usual mammary tumor associated with aggressive clinical pregnancy-associated breast cancer[J]. Int J Cancer,2018,
course[J]. Pathol Res Pract,1997,193(11):783-787. 142(7):1343-1354.
[31] MURRAY EM,WERNER ID. Pregnancy and abortion in [46] BORGES VF,SCHEDIN PJ. Pregnancy-associated breast
中国药房 2020年第31卷第8期 China Pharmacy 2020 Vol. 31 No. 8 ·995 ·